Login

Ryu Young-sang, CEO of SK Telecom, speaks with CNBC's Arjun Kharpal at Mobile World Congress in Barcelona, Spain. 00:10:00

Share On Facebook Share On Twitter

Ryu Young Sang "James". President/CEO, SK Telecom Co Ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Greg Foran: Introducing Air New Zealand's New CEO | Greg Foran, CEO, Air New Zealand Ltd .
00:10:00
"Transforming Global Food Systems: Insights from Jennifer Morris of Nature Conservancy"
00:10:00
Live 401(k) Review: Understanding Target Date Funds, Asset Allocation, and Fee Avoidance
00:10:00
focused on post-revenue seed-to-series-A investments in companies|Clay Gordon,Partner,Stout Street Capital
00:10:00
Inside Google: Sundar Pichai on AI, Innovation, and the Future| Sundar Pichai, CEO, Google
00:10:00
CRU Insights: Super Cycles, Lithium Deficits, and the Future of Rare Earths in the Green Transition
00:10:00
Accelerating Sustainability: Waste Plastic Upcycling Pioneers Expansion | Niels Stielund, Chairman, Wpu Waste Plastic Upcycling A/S.
00:10:00
Budimex Mobility's Market Development: Insights from Ksawery Lesiecki, Market Development Manager
00:10:00
Insights from Industry Leader Oliver Tan on Citycore's Expansion and Strategies |Oliver Y. Tan, CEO, Citicore Energy REIT Corp.
00:10:00
Reflecting on an Exceptional Week of Competitive Golf and Philanthropy | Jonathan Thomas, CEO , American Century Investments.
00:00:00
Stéphane Boissel, CEO, Txcell SATXCL:PAR
00:10:00
Advanced cancer therapy shows promising results in licensing agreement announcement |Michael Baker, CEO, Arovella Therapeutics Ltd.

© 2017 - Neuhu+